Colin Sweeney

Colin Sweeney

UNVERIFIED PROFILE

Are you Colin Sweeney?   Register this Author

Register author
Colin Sweeney

Colin Sweeney

Publications by authors named "Colin Sweeney"

Are you Colin Sweeney?   Register this Author

21Publications

639Reads

36Profile Views

Gene Editing in Chronic Granulomatous Disease.

Methods Mol Biol 2019 ;1982:623-665

Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-9424-3_36DOI Listing
January 2020

Using CRISPR/Cas9 for Gene Knockout in Immunodeficient NSG Mice.

Methods Mol Biol 2019 ;1874:139-168

Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-1-4939-8831-0_8
Publisher Site
http://dx.doi.org/10.1007/978-1-4939-8831-0_8DOI Listing
June 2019

Myeloid Conditioning with c-kit-Targeted CAR-T Cells Enables Donor Stem Cell Engraftment.

Mol Ther 2018 05 10;26(5):1181-1197. Epub 2018 Mar 10.

Genetic Immunotherapy Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2018.03.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993968PMC
May 2018

CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem-Cell Gene Therapy Transplants.

Hum Gene Ther 2017 07 6;28(7):565-575. Epub 2017 Mar 6.

1 Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases , National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/hum.2017.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549813PMC
July 2017

Molecular Analysis of Neutrophil Differentiation from Human Induced Pluripotent Stem Cells Delineates the Kinetics of Key Regulators of Hematopoiesis.

Stem Cells 2016 06 29;34(6):1513-26. Epub 2016 Feb 29.

Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/stem.2332DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892955PMC
June 2016

Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis.

Stem Cell Res 2015 May 7;14(3):323-38. Epub 2015 Feb 7.

Tumor Vaccine and Biotechnology Branch, Division of Cellular and Gene Therapies, FDA, Center for Biologics Evaluation and Research, Bethesda, MD 20892-4555, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2015.01.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778352PMC
May 2015

Generation of functionally mature neutrophils from induced pluripotent stem cells.

Methods Mol Biol 2014 ;1124:189-206

Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-1-62703-845-4_12
Publisher Site
http://dx.doi.org/10.1007/978-1-62703-845-4_12DOI Listing
October 2014

Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells.

Blood 2013 Apr 5;121(14):e98-107. Epub 2013 Feb 5.

Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-1456, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-03-420273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617640PMC
April 2013

Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting.

Blood 2011 May 16;117(21):5561-72. Epub 2011 Mar 16.

Division of Hematology, Department of Medicine, and Stem Cell Program, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-12-328161DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110021PMC
May 2011

Functional neutrophils from human ES cells.

Blood 2009 Jun;113(26):6503-5

National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-04-214320DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710912PMC
June 2009

Trimetrexate inhibits progression of the murine 32Dp210 model of chronic myeloid leukemia in animals expressing drug-resistant dihydrofolate reductase.

Cancer Res 2003 Mar;63(6):1304-10

Gene Therapy Program, Institute of Human Genetics, Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, Minnesota 55455, USA.

View Article

Download full-text PDF

Source
March 2003

Methotrexate exacerbates tumor progression in a murine model of chronic myeloid leukemia.

J Pharmacol Exp Ther 2002 Mar;300(3):1075-84

Gene Therapy Program, Institute of Human Genetics, Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, Minnesota 55455, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.300.3.1075DOI Listing
March 2002